Liquid Dosage
As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.
GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.
In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.
GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.
Mostrando 4 de 8

A GEA Hilge oferece uma linha versátil de bombas centrífugas e de deslocamento positivo para uma ampla variedade de aplicações sensíveis nas indústrias de bebidas, alimentícia e farmacêutica.

GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.

GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.

Ninguém sabe mais sobre secagem por pulverização do que a GEA. Nossa experiência foi adquirida ao longo de quase um século, período durante o qual projetamos e fornecemos mais de 10.000 plantas de secagem por pulverização da GEA em todo o mundo e realizamos testes para clientes em diferentes indústrias.
GEA’s past fiscal year was one of significant growth and further profitability gains. In particular, the technology group substantially increased order intake, with all divisions contributing here. GEA also made progress in all Mission 30 strategic growth areas. In addition, GEA met key interim targets under its climate plan ahead of schedule. Major milestones in fiscal year 2025 were admission to the DAX index, the award of one of the largest contracts in the company’s history, and streamlining of the corporate structure.
Graças a uma nova unidade de fabricação, o SmartParc, os processadores de alimentos do Reino Unido estão reduzindo seus custos operacionais e suas emissões. Com a tecnologia de aquecimento e resfriamento da GEA em seu núcleo, esse modelo de produção colaborativa demonstra como a inovação está acelerando as ambições de net-zero do setor.
"Cozinhar ovos é como cozinhar cerveja". É o tipo de comparação que faz você sorrir - depois, dá um clique: Algo complexo de repente parece simples. Por meio desse filme pessoal, ambientado no coração agrícola dos EUA, exploramos a fermentação de precisão e o trabalho real necessário para transformar uma ideia em alimentos.